{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:36:50Z","timestamp":1759333010815,"version":"3.41.2"},"reference-count":18,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T00:00:00Z","timestamp":1632441600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p><jats:bold>Objective:<\/jats:bold> Coronavirus disease (COVID-19) vaccine-induced immune thrombotic thrombocytopenia (VITT) is a rare but fatal complication observed within 2 weeks of adenovirus-vectored vaccination.<\/jats:p><jats:p><jats:bold>Case Report:<\/jats:bold> A 52-year-old male patient, with a family history of autoimmune diseases, presented with a new onset of worsening headache with nausea and vomiting post-vaccination. The patient was diagnosed with VITT based on laboratory findings demonstrating thrombocytopenia, elevated D-dimer, and dural sinus thrombosis identified on neuroimaging. The patient was successfully treated with high-dose immunoglobulin, steroids, and non-heparin anticoagulants, without any neurologic sequelae. Finally, a confirmatory test with anti-platelet factor 4 antibody was strongly positive.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> Physicians should be vigilant when treating patients presenting with new-onset thunderclap headache, progressive worsening headache, and awakening headache accompanied by nausea or vomiting after vaccination, even if no definite clinical neurological deficits are identified. Emergency laboratory test results for demonstrating elevated D-dimer levels, decreased platelet count, and neuroimaging correlation are integral for diagnosis and must be the standard protocol. Treatment with non-heparin anticoagulants, high-dose intravenous immunoglobulin, and steroids that halt or slow the immune-mediated prothrombotic process should be initiated immediately. Considering the high mortality rate of VITT, treatment should be initiated prior to confirmatory test results.<\/jats:p>","DOI":"10.3389\/fneur.2021.738329","type":"journal-article","created":{"date-parts":[[2021,9,25]],"date-time":"2021-09-25T00:47:05Z","timestamp":1632530825000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Cerebral Venous Sinus Thrombosis, Pulmonary Embolism, and Thrombocytopenia After COVID-19 Vaccination in a Taiwanese Man: A Case Report and Literature Review"],"prefix":"10.3389","volume":"12","author":[{"given":"Wei","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chien-An","family":"Ko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yueh-Feng","family":"Sung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeu-Chin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiunn-Tay","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun-Qian","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Kai","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,9,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1001\/jama.2020.12839","article-title":"Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review","volume":"324","author":"Wiersinga","year":"2020","journal-title":"JAMA"},{"key":"B2","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1001\/jamaneurol.2020.1127","article-title":"Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China","volume":"77","author":"Mao","year":"2020","journal-title":"JAMA Neurol."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1111\/ene.14727.","article-title":"Cerebral venous thrombosis and severe acute respiratory syndrome coronavirus-2 infection: a systematic review and meta-analysis","volume":"11","author":"Baldini","year":"2021","journal-title":"Eur J Neurol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"105549","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.105549","article-title":"Stroke as a neurological complication of COVID-19: a systematic review and meta-analysis of incidence, outcomes and predictors","volume":"30","author":"Siow","year":"2021","journal-title":"J Stroke Cerebrovasc Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1093\/infdis\/jiaa609","article-title":"Clinical presentation and outcomes of severe acute respiratory syndrome coronavirus 2-related encephalitis: the ENCOVID multicenter study","volume":"223","author":"Pilotto","year":"2021","journal-title":"J Infect Dis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1007\/s00415-020-10124-x","article-title":"Guillain-Barr\u00e9 syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases","volume":"268","author":"Abu-Rumeileh","year":"2021","journal-title":"J Neurol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1056\/NEJMoa2105385","article-title":"Pathologic antibodies to platelet factor 4 after ChAdOx1 nCoV-19 vaccination","volume":"384","author":"Scully","year":"2021","journal-title":"N Engl J Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1056\/NEJMoa2104840","article-title":"Thrombotic thrombocytopenia after ChAdOx1 nCov-19 VACCINATION","volume":"384","author":"Greinacher","year":"2021","journal-title":"N Engl J Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1056\/NEJMoa2104882","article-title":"Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination","volume":"384","author":"Schultz","year":"2021","journal-title":"N Engl J Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.bbi.2021.04.006","article-title":"Cerebral venous sinus thrombosis and thrombocytopenia after COVID-19 vaccination - a report of two UK cases","volume":"95","author":"Mehta","year":"2021","journal-title":"Brain Behav Immun."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.3390\/jcm10081599","article-title":"Thrombocytopenia and intracranial venous sinus thrombosis after \u201cCOVID-19 vaccine AstraZeneca\u201d exposure","volume":"10","author":"Wolf","year":"2021","journal-title":"J Clin Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"285","DOI":"10.3390\/jpm11040285","article-title":"A rare case of cerebral venous thrombosis and disseminated intravascular coagulation temporally associated to the COVID-19 vaccine administration","volume":"11","author":"D'Agostino","year":"2021","journal-title":"J Pers Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.1001\/jama.2021.7517","article-title":"US case reports of cerebral venous sinus thrombosis with thrombocytopenia after Ad26.COV2.S vaccination, March 2 to April 21, 2021","volume":"325","author":"See","year":"2021","journal-title":"JAMA."},{"key":"B14","doi-asserted-by":"publisher","first-page":"102663","DOI":"10.1016\/j.jaut.2021.102663","article-title":"Perspectives on vaccine induced thrombotic thrombocytopenia","volume":"121","author":"Dotan","year":"2021","journal-title":"J Autoimmun."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1056\/NEJMc1510993","article-title":"Heparin-induced thrombocytopenia","volume":"373","author":"Greinacher","year":"2015","journal-title":"N Engl J Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1093\/annonc\/mdf117","article-title":"Treatment with the novel anti-angiogenic agent PI-88 is associated with immune-mediated thrombocytopenia","volume":"13","author":"Rosenthal","year":"2002","journal-title":"Ann Oncol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3390\/antib9040052","article-title":"Structural features and PF4 functions that occur in heparin-induced thrombocytopenia (HIT) complicated by COVID-19","volume":"9","author":"Cai","year":"2020","journal-title":"Antibodies."},{"key":"B18","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1055\/a-1469-7481","article-title":"Diagnosis and management of vaccine-related thrombosis following AstraZeneca COVID-19 vaccination: guidance statement from the GTH","volume":"41","author":"Oldenburg","year":"2021","journal-title":"Hamostaseologie."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.738329\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,25]],"date-time":"2021-09-25T00:47:12Z","timestamp":1632530832000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.738329\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,24]]},"references-count":18,"alternative-id":["10.3389\/fneur.2021.738329"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2021.738329","relation":{},"ISSN":["1664-2295"],"issn-type":[{"type":"electronic","value":"1664-2295"}],"subject":[],"published":{"date-parts":[[2021,9,24]]},"article-number":"738329"}}